From Assessment to Planning Injection Safety Assessments coordinated by WHO/Vaccines and Biologicals in the Eastern Mediterranean Region Carsten Mantel,

Slides:



Advertisements
Similar presentations
Números.
Advertisements

Progress in Measles Control in the African Region Annual Measles Partnership meeting Feb 2007 Washington DC.
EuroCondens SGB E.
Disability status in Ethiopia in 1984, 1994 & 2007 population and housing sensus Ehete Bekele Seyoum ESA/STAT/AC.219/25.
Knowledge Dietary Managers Association 1 DMA Certification Exam Blueprint and Curriculum Development.
1 Introduction to Safety Management April Objective The objective of this presentation is to highlight some of the basic elements of Safety Management.
EQUS Conference - Brussels, June 16, 2011 Ambros Uchtenhagen, Michael Schaub Minimum Quality Standards in the field of Drug Demand Reduction Parallel Session.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
GOALS FOR TODAY Understand how to write a HACCP Plan
India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.
Injection Safety Practices TOT Refresher Training of EPI Technicians Abbottabad -23 Feb 2012 Dr Bilal Ahmed Immunization Officer UNICEF.
Multiple Indicator Cluster Surveys Survey Design Workshop MICS Technical Assistance MICS Survey Design Workshop.
The basics for simulations
Planning for a safe syringe disposal system for Immunization Service Delivery Part I Options for syringe waste disposal Part II Weighing the options.
TCCI Barometer March “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
TCCI Barometer March “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
1 Surveys in Humanitarian Emergencies. 2 Methods of Data Collection AssessmentSurveySurveillance Objective Rapid appraisal Medium-term appraisal Continuous.
Promoting Rational Drug Use in the Community Monitoring and evaluation.
CARMEN Policy Observatory and Dialogue Proposal Presentation to the CARMEN Directing Board Meeting San Juan, Puerto Rico 30 June 2003.
Module 6: Safety At the HIV Rapid Testing Site. Lab workersHealth workersCounselors 2 The Lab Quality System Process Control Quality Control & Specimen.
Towards a model M&E system for AIDS programs Kampala April
Progressive Aerobic Cardiovascular Endurance Run
TCCI Barometer September “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Before Between After.
Benjamin Banneker Charter Academy of Technology Making AYP Benjamin Banneker Charter Academy of Technology Making AYP.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Foundation Stage Results CLL (6 or above) 79% 73.5%79.4%86.5% M (6 or above) 91%99%97%99% PSE (6 or above) 96%84%100%91.2%97.3% CLL.
Measles elimination in the African Region- Regional updates
10/07/02 Waste Management Planning Process in St Louis - Sénégal P. Jaillard, AMP, CVP/PATH SIGN Meeting, Phnom Penh.
ADVANCING HEALTH CARE QUALITY IN 2007 AND BEYOND Margaret E. O’Kane President, NCQA.
Static Equilibrium; Elasticity and Fracture
Resistência dos Materiais, 5ª ed.
Chart Deception Main Source: How to Lie with Charts, by Gerald E. Jones Dr. Michael R. Hyman, NMSU.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.
Injection Safety in EPI: More than just AD Syringes and Safety Boxes World Health Organization HTP/V&B/EPI.
Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Richard M. Carr.
Synergy and Partnership for Injection Safety: the Senegal experience Jules Millogo, MD, MSc Immunization Advisor BASICS II A USAID-financed project administered.
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Richard M. Carr.
Plan of Action to improve injection Safety Within the EPI.
The WHO injection safety assessment tool: first results SIGN Meeting 2001 New Delhi, India.
SIGN Rapid Assessment Survey Northern Areas, Pakistan Lubna Samad, MRCS, FCPS Pediatric Surgeon National Institute of Child Health.
Countries Experiences on Access to Injection Equipment Sophie Logez WHO/BCT/DCT Phnom Penh, October 2002.
Indonesia country office Household and health facility surveys in Indonesia Indonesia country team Jakarta, Indonesia.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.
Safe and Appropriate Use of Injection Activities of WHO’s Department of Blood Safety and Clinical Technology (BCT) Yvan Hutin Annual SIGN Meeting New Delhi.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
World Health Organization Eastern Mediterranean Region.
Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.
A media campaign to promote safe immunization injections in Tanzania (This presentation was modified from its original layout. It has been adapted for.
Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.
Injection Safety in the Context of and. “The only thing standing in the way of saving millions of additional kids is ensuring an adequate supply of vaccines.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
Journey For Scaling up Family Practice
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
Overview of host organization
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Ensuring Injection Safety during Rubella Immunization Campaigns
Presentation transcript:

From Assessment to Planning Injection Safety Assessments coordinated by WHO/Vaccines and Biologicals in the Eastern Mediterranean Region Carsten Mantel, MD, MPH WHO STC

WHO/V&B/VAM Assessment of Injection Safety WHO/V&B Tool C: Rationale, Objectives, Methods Experience from 22 country assessments WHO/EMR: Regional Injection Safety Assessment Regional Injection Safety Strategy Regional Injection Safety Plan of Action

Injection Safety: Critical Issues The risk to the recipient Re-use of syringes or needles Use of non-sterile equipment Risk to the health care worker Inappropriate waste collection Risk to the community Inappropriate waste disposal Reuse of equipment Unsafe collection Unsafe disposal

Assessment of Injection Safety: Tool C Rationale zDescribes injection practices in a standardised and representative way zIdentifies detailed problems in injection practices zIdentifies local issues to design effective, efficient interventions zProvides baseline information and indicators for monitoring progress

Assessment of Injection Safety: Tool C Objectives z To determine if a facility meets necessary requirements for staff competence, equipment, supplies, and waste disposal. z To assess if injections are administered according to recommended best practices. z To identify the unsafe practices that may lead to infections and that should be targeted by interventions. z To estimate the proportion of health-care facilities where injection practices are safe.

Assessment of Injection Safety: Tool C Methods Standardized and representative method to allow for: Measuring and documenting progress Comparison across countries Simple/structured and flexible (2-3 weeks) To be adjusted to country needs (other issues at health facility can be looked at simultaneously) Need to link with change plan of action.

Assessment of Injection Safety: Tool C Development Collaboration between SIGN, BASICS and WHO/V&B Ohio State University: Statistical advice on sampling strategy Computer simulation studies of sampling design

Assessment of Injection Safety: Tool C Sampling Cross-sectional observational study Two-stage cluster sampling with probability proportional to size of population 8 districts randomly selected 10 health care facilities visited in each district èRepresentative of the country èWith around 10% precision of the estimate

Assessment of Injection Safety: Tool C Data Collection Observation of supplies: Type and number of syringes and needles Number of safety boxes, sharps containers Type of waste disposal Observation of injections: Immunisation and curative departments Interview of healthcare workers: With injection provider With the supervisor of the centre

Assessment of Injection Safety: Tool C Data Analysis Data Entry in Epi Info Data Analysis in Epi Info and e.g. Stata: Calculation of means and proportions Calculation of 95% confidence intervals (binomial) Cluster sampling design taken into account

Assessments planned Assessments done Tool C Injection Safety Assessments Burkina Faso, Chad, Djibuti, Egypt, Eritrea, Ethiopia, Gambia, Guinea, Honduras, Kyrgyzstan, Morocco, Nepal, Niger, Oman, Pakistan, Paraguay, Syria, Sudan, Tunesia, Yemen, Zambia, Zimbabwe

Results: Injection Equipment 20 country reports available as of June 2002 zSterilizable equipment in majority of facilities8/20 zAD-syringes for all immunizations2/20 zDisposable equipment for curative injections 20/20

Results: Risk to Injection Recipients z100% use of sterile equipment for all observed injections: 4/18 countries z100% use of sterile equipment for all observed immunization injections: 9/17 countries

Results: Risk to Injection Recipients Countries using disposable equipment (n=12): yIn 9 countries 100% of immunizations are safe Countries using sterilizable equipment (n=8): yIn 1 country 100% of immunizations are safe yIn all facilities leaking sterilizers, no regular use of time-steam-temperature spots

Results: Risk to Injection Recipients Relative Risk for safe immunization injections for countries using disposable equipment v.s countries using sterilizable equipment OR 14.0 (95% CI: )

Results: Risk to the Health Care Worker zUse of safety-boxes % zNo sharps in open containers % zNo two-hands recapping % zNo needle-stick injuries in the last 12 month % zMean number of needle sticks per person and year 1 - 9

Results: Risk to the Community zNo sharps in the surroundings % zOpen burning or unsupervised dumping of sharps waste18 -64% zHealth care waste policy 0 - 9%

Discrepancy between IS policy and actual findings (Country 1) zCountry policy: Use of disposable injection equipment z84% of the injections are given with sterilizables zSterilizers without leaks only in 84%, only in 23% spare parts and in 7% TST spots available to register sterility

Discrepancy between IS policy and actual findings (Country 2) zCountry policy: Use of sterilizable injection equipment for immunizations zOnly 4% of health facilities in the country are using sterilizable equipment zClients are purchasing the injection material locally

WHO Eastern Mediterranean Region 23 countries with 482 Mio. total population (2000)

WHO/EMR: Injection Safety Situation Standardised assessments performed in 9/23 countries representing 65% of EMR population Additional data used: WHO/UNICEF Joint Reporting Forms on vaccine-preventable diseases SIGN reports ATT reports GAVI applications re: injection safety Expert knowledge (Delphi estimates) of national EPI managers Published scientific papers (Egypt, Pakistan)

Palestine Bahrain WHO/EMR: Injection Safety Assessments Covering 65% of EMR population

WHO/EMR: Risk to Injection Recipients Proportions weighted by population figures

Palestine Bahrain WHO/EMR: Immunization Safety 2002 > 95% safe injections % safe injections % safe injections % safe injections 70% safe injections

WHO/EMR: Equipment and Supplies Proportions weighted by population figures

Palestine Bahrain WHO/EMR: AD Injection Equipment At least partially available for 51% of EMR population

WHO/EMR: Risk to Health Care Workers Data from 7 countries - weighted by population figures

Palestine Bahrain WHO/EMR: Safety Boxes At least partially available for 93% of EMR population

WHO/EMR: Risk to Health Care Workers Proportions weighted by population figures

WHO/EMR: Risk to the Community Proportion weighted by population figures

WHO/EMR: Sharps Waste Disposal Proportions weighted by population figures

WHO/EMR: Summary Estimates Weighted Proportion Risk to Recipients (EPI and curative): Non-sterile injections34% Risk to Health Care Workers: Sharps in open containers71% Two-hands re-capping60% Needle-stick injuries (admitted)50% Risk to the Community: Unsafe sharps waste disposal85%

Pakistan Summary Estimates % 95% CI Risk to Patients: Non-sterile injections64%( ) Risk to Health Care Workers: Sharps in open containers92%( ) Two-hands re-capping83%( ) Needle-stick injuries (admitted)46%( ) Risk to the Community: Unsafe sharps waste disposal94%( )

Planning or Quality Cycle Benchmarking Implementation Assessment PlanningMonitoring Evaluation

WHO/EMR Regional Injection Safety Goals Ensure the safety of all immunization injections in all member countries. Extend successful injection safety strategies and activities to other parts of health care services.

WHO/EMR: Regional Injection Safety Targets All countries of the EMR will... have reliable baseline data on injection safety by the end of have declared their political commitment to injection safety and have developed national policies, guidelines and plans of action on injection safety by the end of have sustained public information and communication activities and behaviour change strategies to increase injection safety by the end of 2005.

WHO/EMR: Regional Injection Safety Targets All countries of the EMR will... have strengthened their management capacity and improved human resources development in all issues related to injection safety by the end of have assured that no reuse of injection equipment occurs at any time and that safe injection equipment and safety boxes are supplied bundled with all vaccines by the end of 2004.

WHO/EMR: Regional Injection Safety Targets All countries of the EMR will... have assured the safe collection, treatment and destruction of sharps waste by the end of have a regular reporting system and the capacity to supervise, monitor and evaluate injection safety programmes by the end of have extended successful injection safety strategies and activities from immunization services to other parts of the health care services by the end of 2005.

WHO/EMR: Regional Injection Safety Plan of Action Eight main activities according to established targets Additional resource requirements : for regional-level activities: 655,000 USD for country-level activities: 805,000 USD

WHO/EMR: Regional Injection Safety Milestones and Indicators Milestones set for Measurable indicators (input, process, outcome) suggested for regional and country level

Acknowledgements Dr. Julia Fitzner, WHO/V&B/VAM Dr. Phillipe Duclos, WHO/V&B/VAM Dr. Ezzedine Mohsnie, WHO/EMRO Dr. Yvan Hutin, WHO/BCT All collaborators, counterparts in Ministries of Health, field workers, health facility staff, patients and vaccinees